The Use of a Hydrogel Matrix for Controlled Delivery of Niacin to the Gastrointestinal Tract for Treatment of Hyperlipidemia

被引:11
作者
Sirc, J. [1 ]
Hrib, J. [1 ]
Vetrik, M. [1 ]
Hobzova, R. [1 ]
Zak, A. [2 ]
Stankova, B. [2 ]
Slanar, O. [3 ]
Hromadka, R. [4 ]
Sandrikova, V. [4 ]
Michalek, J. [1 ]
机构
[1] Acad Sci Czech Republ, Inst Macromol Chem, Heyrovskeho Nam 2, CR-16206 Prague 6, Czech Republic
[2] Charles Univ Prague, Fac Med 1, Dept Med 4, Prague, Czech Republic
[3] Charles Univ Prague, Fac Med 1, Inst Pharmacol, Prague, Czech Republic
[4] C2P Ltd, Ctr Res & Dev, Chlumec Nad Cidlinou, Czech Republic
关键词
Niacin; Hyperlipidemia; Hydrogel; Poly(2-hydroxyethyl methacrylate); Polyvinylpyrrolidone; Controlled release; GELS;
D O I
10.33549/physiolres.933142
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Hyperlipidemia treatment based on niacin requires gastrointestinal administration of relatively high doses. The recommended dietary allowance of niacin as vitamin B3 is 14 to 16 mg daily in adults, while the doses of niacin used in the treatment of hyperlipidemia are generally in the range of 1 to 3 g. Administration of such large doses requires a high concentration of the active compound in the tablet and proper control of the drug release. In this study, a hydrogel matrix based on poly(2-hydroxyethyl methacrylate) and polyvinylpyrrolidone was investigated as delivery vehicle for controlled NA release into the gastrointestinal environment. The prepared hydrogel matrices varied in used monomer and crosslinker types and concentrations. The content of NA in tablets was between 65-80 %. The release profiles of NA from tablets were examined under three different pH values (1, 4.5 and 6.8) over the time period of 30 h. The effects of the monomer ratio, the crosslinking of the polymer network, and the solubility of niacin during drug release under various pH are discussed. The results showed that the release time period can be achieved in a relatively wide range of time and can be adjusted according to the medical requirements.
引用
收藏
页码:S51 / S60
页数:10
相关论文
共 23 条
[1]  
[Anonymous], 2009, CLIN LIPIDOLOGY COMP
[2]  
[Anonymous], 1966, PATENT, Patent No. [GB 1024400, 1024400]
[3]  
[Anonymous], 2010, J HOPKINS TXB DYSLIP
[4]   Hydrogels for oral drug delivery of peptides: synthesis and characterization [J].
Bajpai, SK .
JOURNAL OF APPLIED POLYMER SCIENCE, 2002, 83 (08) :1717-1729
[5]  
BASHIR A, 2013, MIDDLE EAST J SCI RE, V14, P273, DOI DOI 10.5829/idosi.mejsr.2013.14.2.7391
[6]   Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy [J].
Boden, William E. ;
Probstfield, Jeffrey L. ;
Anderson, Todd ;
Chaitman, Bernard R. ;
Desvignes-Nickens, Patrice ;
Koprowicz, Kent ;
McBride, Ruth ;
Teo, Koon ;
Weintraub, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24) :2255-2267
[7]   THE REMOVAL OF RESIDUALS AND OLIGOMERS FROM POLY(2-HYDROXYETHYLMETHACRYLATE) [J].
BRYNDA, E ;
STOL, M ;
CHYTRY, V ;
CIFKOVA, I .
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1985, 19 (09) :1169-1179
[8]  
Buhler V, 2005, Polyvinylpyrrolidone excipients for pharmaceuticals: povidone, crospovidone and copovidone
[9]   Povidone-iodine solution in wound treatment [J].
Burks, RI .
PHYSICAL THERAPY, 1998, 78 (02) :212-218
[10]   IRRITATION EFFECTS OF RESIDUAL PRODUCTS DERIVED FROM P(HEMA) GELS .2. COMPOUNDS EXTRACTED FROM HYDROGELS [J].
CIFKOVA, I ;
BRYNDA, E ;
MANDYS, V ;
STOL, M .
BIOMATERIALS, 1988, 9 (04) :372-375